The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review

CONCLUSION: Etonogestrel- and segesterone-releasing progestin subdermal implants appear to improve endometriosis-related pain symptoms and quality of life, and may provide an additional component in the management of endometriosis. However, this systematic review is limited by a small sample size and heterogeneity in the data. As such, larger prospective randomized trials are needed to guide further management.PROSPERO Registration: CRD42021225665.PMID:35048754 | DOI:10.1080/03007995.2022.2031144
Source: Current Medical Research and Opinion - Category: Research Authors: Source Type: research